Pear Therapeutics Stock
Digital Therapeutics Platform
Sign up today and learn more about Pear Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Pear Therapeutics Stock
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to help treat disease and enhance the efficacy of pharmaceuticals. The company's platform aims to combine novel digital interventions with drugs to enhance efficacy, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payers. The company has three FDA-approved products for substance use disorders, opioid use disorders, and insomnia.
Pear Therapeutics was founded in 2013 and is headquartered in Boston, Massachusetts. Notable investors include Softbank Vision Fund, Temasek Holdings, and Perceptive Advisors.
Investors
5AM Ventures
Arboretum Ventures
Blue Water Life Science Fund
Bridge Builders Collaborative
Crimsonox Capital
dRx Capital
EDBI
Magic Leap, DataRobot, Nature's Fynd, Voyager Innovations, Welltok, Seismic, Inari, WuXi NextCODE, Sprinklr, Druva
Forth Management
Jazz Venture Partners
Pear Therapeutics, Akili Interactive Labs, Pymetrics, AllStripes, Halo Neuroscience
Novartis
Pilot House Ventures
QUAD Investment Management
Sarissa Capital Management
Shanda Group
Temasek Holdings
PharmEasy, Tokopedia, Ola, Magic Leap, DoorDash, Impossible Foods, Commonwealth Fusion, Wish, Snyk, AvidXchange
Trustbridge Partners
Funding History
| February 2016 | $18.7M |
|---|---|
| December 2017 | $51.0M |
| December 2018 | $64.4M |
| December 2020 | $32.0M |
| December 2020 | $107M |
Management
Chief Executive Officer
Corey McCann
Chief Financial Officer
Chris Guiffre
Press
massdevice - Oct, 13 2021
Massachusetts offers Medicaid coverage for Pear Therapeutics’ digital therapeuticsshar - Oct, 13 2021
MassHealth to cover Pear Therapeutics' reSET and reSET-Odrugdeliverybusiness - Sep, 16 2021
Pear Therapeutics touts real-world data for reSET-O prescription digital therapeuticdrugdeliverybusiness - Jul, 14 2021
Pear Therapeutics touts 9-month data for reSET-Oow - Jun, 22 2021
Pear Therapeutics to go public via SPAC mergerwsj - Jun, 22 2021
Pear Therapeutics to Go Public in Roughly $1.6 Billion SPAC Dealbuff - Apr, 23 2021
Ohio is third state to fund Pear’s digital therapeutics to tackle addictiondrugdeliverybusiness - Apr, 6 2021
Pear Therapeutics inks multiple agreements to expand digital therapeutic platformzpr - Apr, 6 2021
Pear Therapeutics Expands Platform with Digital Biomarkers, Machine Learning Algorithms and Sensor-Based Technologiesmobihealthnews - Mar, 1 2021
Pear Therapeutics tags another $20M to December's Series D rounddrugdeliverybusiness - Feb, 23 2021
Pear Therapeutics touts cost-effectiveness of opioid use disorder treatmentmedcitynews - Jan, 14 2021
‘Smart pill’ startup etectRx strikes partnership with Pear TherapeuticsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
